EMEA (Europe, Middle East and Africa) HER2 Antibodies Market Report 2017

October 2017 | 102 pages | ID: E0A9759C23DPEN
QYResearch

Abstracts

In this report, the EMEA HER2 Antibodies market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), revenue (Million USD), market share and growth rate of HER2 Antibodies for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA HER2 Antibodies market competition by top manufacturers/players, with HER2 Antibodies sales volume (MT), price (USD/Kg), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novartis AG
• Pfizer, Inc.
• Genentech Inc. (F. Hoffmann-La Roche Ltd.)
• Abnova Corporation
• InvivoGen
• Celltrion, Inc.
• Biocon Limited
• Bio-Techne (Novus Biologicals, LLC)

On the basis of product, this report displays the sales volume (MT), revenue (Million USD), product price (USD/Kg), market share and growth rate of each type, primarily split into

• Trastuzumab
• Lapatinib'
• Ado-trastuzumab emtansine'
• Pertuzumab ''
• Everolimus''

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (MT), market share and growth rate of HER2 Antibodies for each application, including

• Application 1
• Application 2

Contents

EMEA (Europe, Middle East and Africa) HER2 Antibodies Market Report 2017

1 HER2 ANTIBODIES OVERVIEW

1.1 Product Overview and Scope of HER2 Antibodies
1.2 Classification of HER2 Antibodies
  1.2.1 EMEA HER2 Antibodies Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA HER2 Antibodies Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Trastuzumab
  1.2.4 Lapatinib?
  1.2.5 Ado-trastuzumab emtansine?
  1.2.6 Pertuzumab ??
  1.2.7 Everolimus??
1.3 EMEA HER2 Antibodies Market by Application/End Users
  1.3.1 EMEA HER2 Antibodies Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.1 Application
  1.3.2 Application
1.4 EMEA HER2 Antibodies Market by Region
  1.4.1 EMEA HER2 Antibodies Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of HER2 Antibodies (2012-2022)
  1.5.1 EMEA HER2 Antibodies Sales and Growth Rate (2012-2022)
  1.5.2 EMEA HER2 Antibodies Revenue and Growth Rate (2012-2022)

2 EMEA HER2 ANTIBODIES COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA HER2 Antibodies Market Competition by Players/Manufacturers
  2.1.1 EMEA HER2 Antibodies Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA HER2 Antibodies Revenue and Share by Players (2012-2017)
  2.1.3 EMEA HER2 Antibodies Sale Price by Players (2012-2017)
2.2 EMEA HER2 Antibodies (Volume and Value) by Type/Product Category
  2.2.1 EMEA HER2 Antibodies Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA HER2 Antibodies Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA HER2 Antibodies Sale Price by Type (2012-2017)
2.3 EMEA HER2 Antibodies (Volume) by Application
2.4 EMEA HER2 Antibodies (Volume and Value) by Region
  2.4.1 EMEA HER2 Antibodies Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA HER2 Antibodies Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA HER2 Antibodies Sales Price by Region (2012-2017)

3 EUROPE HER2 ANTIBODIES (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe HER2 Antibodies Sales and Value (2012-2017)
  3.1.1 Europe HER2 Antibodies Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe HER2 Antibodies Revenue and Growth Rate (2012-2017)
3.2 Europe HER2 Antibodies Sales and Market Share by Type
3.3 Europe HER2 Antibodies Sales and Market Share by Application
3.4 Europe HER2 Antibodies Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe HER2 Antibodies Sales Volume by Countries (2012-2017)
  3.4.2 Europe HER2 Antibodies Revenue by Countries (2012-2017)
  3.4.3 Germany HER2 Antibodies Sales and Growth Rate (2012-2017)
  3.4.4 France HER2 Antibodies Sales and Growth Rate (2012-2017)
  3.4.5 UK HER2 Antibodies Sales and Growth Rate (2012-2017)
  3.4.6 Russia HER2 Antibodies Sales and Growth Rate (2012-2017)
  3.4.7 Italy HER2 Antibodies Sales and Growth Rate (2012-2017)
  3.4.8 Benelux HER2 Antibodies Sales and Growth Rate (2012-2017)

4 MIDDLE EAST HER2 ANTIBODIES (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East HER2 Antibodies Sales and Value (2012-2017)
  4.1.1 Middle East HER2 Antibodies Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East HER2 Antibodies Revenue and Growth Rate (2012-2017)
4.2 Middle East HER2 Antibodies Sales and Market Share by Type
4.3 Middle East HER2 Antibodies Sales and Market Share by Application
4.4 Middle East HER2 Antibodies Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East HER2 Antibodies Sales Volume by Countries (2012-2017)
  4.4.2 Middle East HER2 Antibodies Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia HER2 Antibodies Sales and Growth Rate (2012-2017)
  4.4.4 Israel HER2 Antibodies Sales and Growth Rate (2012-2017)
  4.4.5 UAE HER2 Antibodies Sales and Growth Rate (2012-2017)
  4.4.6 Iran HER2 Antibodies Sales and Growth Rate (2012-2017)

5 AFRICA HER2 ANTIBODIES (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa HER2 Antibodies Sales and Value (2012-2017)
  5.1.1 Africa HER2 Antibodies Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa HER2 Antibodies Revenue and Growth Rate (2012-2017)
5.2 Africa HER2 Antibodies Sales and Market Share by Type
5.3 Africa HER2 Antibodies Sales and Market Share by Application
5.4 Africa HER2 Antibodies Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa HER2 Antibodies Sales Volume by Countries (2012-2017)
  5.4.2 Africa HER2 Antibodies Revenue by Countries (2012-2017)
  5.4.3 South Africa HER2 Antibodies Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria HER2 Antibodies Sales and Growth Rate (2012-2017)
  5.4.5 Egypt HER2 Antibodies Sales and Growth Rate (2012-2017)
  5.4.6 Algeria HER2 Antibodies Sales and Growth Rate (2012-2017)

6 EMEA HER2 ANTIBODIES MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Novartis AG
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 HER2 Antibodies Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis AG HER2 Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Pfizer, Inc.
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 HER2 Antibodies Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Pfizer, Inc. HER2 Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Genentech Inc. (F. Hoffmann-La Roche Ltd.)
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 HER2 Antibodies Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Genentech Inc. (F. Hoffmann-La Roche Ltd.) HER2 Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Abnova Corporation
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 HER2 Antibodies Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Abnova Corporation HER2 Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 InvivoGen
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 HER2 Antibodies Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 InvivoGen HER2 Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Celltrion, Inc.
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 HER2 Antibodies Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Celltrion, Inc. HER2 Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Biocon Limited
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 HER2 Antibodies Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Biocon Limited HER2 Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Bio-Techne (Novus Biologicals, LLC)
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 HER2 Antibodies Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bio-Techne (Novus Biologicals, LLC) HER2 Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 HER2 ANTIBODIES MANUFACTURING COST ANALYSIS

7.1 HER2 Antibodies Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of HER2 Antibodies

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 HER2 Antibodies Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of HER2 Antibodies Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA HER2 ANTIBODIES MARKET FORECAST (2017-2022)

11.1 EMEA HER2 Antibodies Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA HER2 Antibodies Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA HER2 Antibodies Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA HER2 Antibodies Price and Trend Forecast (2017-2022)
11.2 EMEA HER2 Antibodies Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe HER2 Antibodies Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt HER2 Antibodies Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa HER2 Antibodies Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA HER2 Antibodies Sales Forecast by Type (2017-2022)
11.7 EMEA HER2 Antibodies Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of HER2 Antibodies
Figure EMEA HER2 Antibodies Sales Volume (MT) by Type (2012-2022)
Figure EMEA HER2 Antibodies Sales Volume Market Share by Type (Product Category) in 2016
Figure Trastuzumab Product Picture
Figure Lapatinib? Product Picture
Figure Ado-trastuzumab emtansine? Product Picture
Figure Pertuzumab ?? Product Picture
Figure Everolimus?? Product Picture
Figure EMEA HER2 Antibodies Sales Volume (MT) by Application (2012-2022)
Figure EMEA Sales Market Share of HER2 Antibodies by Application in 2016
Figure Application 1 Examples
Figure Application 2 Examples
Figure EMEA HER2 Antibodies Market Size (Million USD) by Region (2012-2022)
Figure Europe HER2 Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe HER2 Antibodies Revenue (Million USD) Status and Forecast by Countries
Figure Middle East HER2 Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East HER2 Antibodies Revenue (Million USD) Status and Forecast by Countries
Figure Africa HER2 Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa HER2 Antibodies Revenue (Million USD) Status and Forecast by Countries
Figure EMEA HER2 Antibodies Sales Volume and Growth Rate (2012-2022)
Figure EMEA HER2 Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA HER2 Antibodies Market Major Players Product Sales Volume (MT) (2012-2017)
Table EMEA HER2 Antibodies Sales Volume (MT) of Major Players (2012-2017)
Table EMEA HER2 Antibodies Sales Share by Players (2012-2017)
Figure 2016 HER2 Antibodies Sales Share by Players
Figure 2017 HER2 Antibodies Sales Share by Players
Figure EMEA HER2 Antibodies Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA HER2 Antibodies Revenue (Million USD) by Players (2012-2017)
Table EMEA HER2 Antibodies Revenue Share by Players (2012-2017)
Table 2016 EMEA HER2 Antibodies Revenue Share by Players
Table 2017 EMEA HER2 Antibodies Revenue Share by Players
Table EMEA HER2 Antibodies Sale Price (USD/Kg) by Players (2012-2017)
Table EMEA HER2 Antibodies Sales (MT) and Market Share by Type (2012-2017)
Table EMEA HER2 Antibodies Sales Share by Type (2012-2017)
Figure Sales Market Share of HER2 Antibodies by Type (2012-2017)
Figure EMEA HER2 Antibodies Sales Market Share by Type (2012-2017)
Table EMEA HER2 Antibodies Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA HER2 Antibodies Revenue Share by Type (2012-2017)
Figure Revenue Market Share of HER2 Antibodies by Type in 2016
Table EMEA HER2 Antibodies Sale Price (USD/Kg) by Type (2012-2017)
Table EMEA HER2 Antibodies Sales (MT) and Market Share by Application (2012-2017)
Table EMEA HER2 Antibodies Sales Share by Application (2012-2017)
Figure Sales Market Share of HER2 Antibodies by Application (2012-2017)
Figure EMEA HER2 Antibodies Sales Market Share by Application in 2016
Table EMEA HER2 Antibodies Sales (MT) and Market Share by Region (2012-2017)
Table EMEA HER2 Antibodies Sales Share by Region (2012-2017)
Figure Sales Market Share of HER2 Antibodies by Region (2012-2017)
Figure EMEA HER2 Antibodies Sales Market Share in 2016
Table EMEA HER2 Antibodies Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA HER2 Antibodies Revenue Share by Region (2012-2017)
Figure Revenue Market Share of HER2 Antibodies by Region (2012-2017)
Figure EMEA HER2 Antibodies Revenue Market Share Regions in 2016
Table EMEA HER2 Antibodies Sales Price (USD/Kg) by Region (2012-2017)
Figure Europe HER2 Antibodies Sales (MT) and Growth Rate (2012-2017)
Figure Europe HER2 Antibodies Revenue and Growth Rate (2012-2017)
Table Europe HER2 Antibodies Sales (MT) by Type (2012-2017)
Table Europe HER2 Antibodies Market Share by Type (2012-2017)
Figure Europe HER2 Antibodies Market Share by Type in 2016
Table Europe HER2 Antibodies Sales (MT) by Application (2012-2017)
Table Europe HER2 Antibodies Market Share by Application (2012-2017)
Figure Europe HER2 Antibodies Market Share by Application in 2016
Table Europe HER2 Antibodies Sales (MT) by Countries (2012-2017)
Table Europe HER2 Antibodies Sales Market Share by Countries (2012-2017)
Figure Europe HER2 Antibodies Sales Market Share by Countries (2012-2017)
Figure Europe HER2 Antibodies Sales Market Share by Countries in 2016
Table Europe HER2 Antibodies Revenue (Million USD) by Countries (2012-2017)
Table Europe HER2 Antibodies Revenue Market Share by Countries (2012-2017)
Figure Europe HER2 Antibodies Revenue Market Share by Countries (2012-2017)
Figure Europe HER2 Antibodies Revenue Market Share by Countries in 2016
Figure Germany HER2 Antibodies Sales (MT) and Growth Rate (2012-2017)
Figure France HER2 Antibodies Sales (MT) and Growth Rate (2012-2017)
Figure UK HER2 Antibodies Sales (MT) and Growth Rate (2012-2017)
Figure Russia HER2 Antibodies Sales (MT) and Growth Rate (2012-2017)
Figure Italy HER2 Antibodies Sales (MT) and Growth Rate (2012-2017)
Figure Benelux HER2 Antibodies Sales (MT) and Growth Rate (2012-2017)
Figure Middle East HER2 Antibodies Sales (MT) and Growth Rate (2012-2017)
Figure Middle East HER2 Antibodies Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East HER2 Antibodies Sales (MT) by Type (2012-2017)
Table Middle East HER2 Antibodies Market Share by Type (2012-2017)
Figure Middle East HER2 Antibodies Market Share by Type (2012-2017)
Table Middle East HER2 Antibodies Sales (MT) by Applications (2012-2017)
Table Middle East HER2 Antibodies Market Share by Applications (2012-2017)
Figure Middle East HER2 Antibodies Sales Market Share by Application in 2016
Table Middle East HER2 Antibodies Sales Volume (MT) by Countries (2012-2017)
Table Middle East HER2 Antibodies Sales Volume Market Share by Countries (2012-2017)
Figure Middle East HER2 Antibodies Sales Volume Market Share by Countries in 2016
Table Middle East HER2 Antibodies Revenue (Million USD) by Countries (2012-2017)
Table Middle East HER2 Antibodies Revenue Market Share by Countries (2012-2017)
Figure Middle East HER2 Antibodies Revenue Market Share by Countries (2012-2017)
Figure Middle East HER2 Antibodies Revenue Market Share by Countries in 2016
Figure Saudi Arabia HER2 Antibodies Sales (MT) and Growth Rate (2012-2017)
Figure Israel HER2 Antibodies Sales (MT) and Growth Rate (2012-2017)
Figure UAE HER2 Antibodies Sales (MT) and Growth Rate (2012-2017)
Figure Iran HER2 Antibodies Sales (MT) and Growth Rate (2012-2017)
Figure Africa HER2 Antibodies Sales (MT) and Growth Rate (2012-2017)
Figure Africa HER2 Antibodies Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa HER2 Antibodies Sales (MT) by Type (2012-2017)
Table Africa HER2 Antibodies Sales Market Share by Type (2012-2017)
Figure Africa HER2 Antibodies Sales Market Share by Type (2012-2017)
Figure Africa HER2 Antibodies Sales Market Share by Type in 2016
Table Africa HER2 Antibodies Sales (MT) by Application (2012-2017)
Table Africa HER2 Antibodies Sales Market Share by Application (2012-2017)
Figure Africa HER2 Antibodies Sales Market Share by Application (2012-2017)
Table Africa HER2 Antibodies Sales Volume (MT) by Countries (2012-2017)
Table Africa HER2 Antibodies Sales Market Share by Countries (2012-2017)
Figure Africa HER2 Antibodies Sales Market Share by Countries (2012-2017)
Figure Africa HER2 Antibodies Sales Market Share by Countries in 2016
Table Africa HER2 Antibodies Revenue (Million USD) by Countries (2012-2017)
Table Africa HER2 Antibodies Revenue Market Share by Countries (2012-2017)
Figure Africa HER2 Antibodies Revenue Market Share by Countries (2012-2017)
Figure Africa HER2 Antibodies Revenue Market Share by Countries in 2016
Figure South Africa HER2 Antibodies Sales (MT) and Growth Rate (2012-2017)
Figure Nigeria HER2 Antibodies Sales (MT) and Growth Rate (2012-2017)
Figure Egypt HER2 Antibodies Sales (MT) and Growth Rate (2012-2017)
Figure Algeria HER2 Antibodies Sales (MT) and Growth Rate (2012-2017)
Table Novartis AG HER2 Antibodies Basic Information List
Table Novartis AG HER2 Antibodies Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Novartis AG HER2 Antibodies Sales (MT) and Growth Rate (2012-2017)
Figure Novartis AG HER2 Antibodies Sales Market Share in EMEA (2012-2017)
Figure Novartis AG HER2 Antibodies Revenue Market Share in EMEA (2012-2017)
Table Pfizer, Inc. HER2 Antibodies Basic Information List
Table Pfizer, Inc. HER2 Antibodies Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pfizer, Inc. HER2 Antibodies Sales (MT) and Growth Rate (2012-2017)
Figure Pfizer, Inc. HER2 Antibodies Sales Market Share in EMEA (2012-2017)
Figure Pfizer, Inc. HER2 Antibodies Revenue Market Share in EMEA (2012-2017)
Table Genentech Inc. (F. Hoffmann-La Roche Ltd.) HER2 Antibodies Basic Information List
Table Genentech Inc. (F. Hoffmann-La Roche Ltd.) HER2 Antibodies Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Genentech Inc. (F. Hoffmann-La Roche Ltd.) HER2 Antibodies Sales (MT) and Growth Rate (2012-2017)
Figure Genentech Inc. (F. Hoffmann-La Roche Ltd.) HER2 Antibodies Sales Market Share in EMEA (2012-2017)
Figure Genentech Inc. (F. Hoffmann-La Roche Ltd.) HER2 Antibodies Revenue Market Share in EMEA (2012-2017)
Table Abnova Corporation HER2 Antibodies Basic Information List
Table Abnova Corporation HER2 Antibodies Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Abnova Corporation HER2 Antibodies Sales (MT) and Growth Rate (2012-2017)
Figure Abnova Corporation HER2 Antibodies Sales Market Share in EMEA (2012-2017)
Figure Abnova Corporation HER2 Antibodies Revenue Market Share in EMEA (2012-2017)
Table InvivoGen HER2 Antibodies Basic Information List
Table InvivoGen HER2 Antibodies Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure InvivoGen HER2 Antibodies Sales (MT) and Growth Rate (2012-2017)
Figure InvivoGen HER2 Antibodies Sales Market Share in EMEA (2012-2017)
Figure InvivoGen HER2 Antibodies Revenue Market Share in EMEA (2012-2017)
Table Celltrion, Inc. HER2 Antibodies Basic Information List
Table Celltrion, Inc. HER2 Antibodies Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Celltrion, Inc. HER2 Antibodies Sales (MT) and Growth Rate (2012-2017)
Figure Celltrion, Inc. HER2 Antibodies Sales Market Share in EMEA (2012-2017)
Figure Celltrion, Inc. HER2 Antibodies Revenue Market Share in EMEA (2012-2017)
Table Biocon Limited HER2 Antibodies Basic Information List
Table Biocon Limited HER2 Antibodies Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Biocon Limited HER2 Antibodies Sales (MT) and Growth Rate (2012-2017)
Figure Biocon Limited HER2 Antibodies Sales Market Share in EMEA (2012-2017)
Figure Biocon Limited HER2 Antibodies Revenue Market Share in EMEA (2012-2017)
Table Bio-Techne (Novus Biologicals, LLC) HER2 Antibodies Basic Information List
Table Bio-Techne (Novus Biologicals, LLC) HER2 Antibodies Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bio-Techne (Novus Biologicals, LLC) HER2 Antibodies Sales (MT) and Growth Rate (2012-2017)
Figure Bio-Techne (Novus Biologicals, LLC) HER2 Antibodies Sales Market Share in EMEA (2012-2017)
Figure Bio-Techne (Novus Biologicals, LLC) HER2 Antibodies Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of HER2 Antibodies
Figure Manufacturing Process Analysis of HER2 Antibodies
Figure HER2 Antibodies Industrial Chain Analysis
Table Raw Materials Sources of HER2 Antibodies Major Manufacturers in 2016
Table Major Buyers of HER2 Antibodies
Table Distributors/Traders List
Figure EMEA HER2 Antibodies Sales (MT) and Growth Rate Forecast (2017-2022)
Figure EMEA HER2 Antibodies Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA HER2 Antibodies Price (USD/Kg) and Trend Forecast (2017-2022)
Table EMEA HER2 Antibodies Sales (MT) Forecast by Region (2017-2022)
Figure EMEA HER2 Antibodies Sales Market Share Forecast by Region (2017-2022)
Table EMEA HER2 Antibodies Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA HER2 Antibodies Revenue Market Share Forecast by Region (2017-2022)
Table Europe HER2 Antibodies Sales (MT) Forecast by Countries (2017-2022)
Figure Europe HER2 Antibodies Sales Market Share Forecast by Countries (2017-2022)
Table Europe HER2 Antibodies Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe HER2 Antibodies Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East HER2 Antibodies Sales (MT) Forecast by Countries (2017-2022)
Figure Middle East HER2 Antibodies Sales Market Share Forecast by Countries (2017-2022)
Table Middle East HER2 Antibodies Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East HER2 Antibodies Revenue Market Share Forecast by Countries (2017-2022)
Table Africa HER2 Antibodies Sales (MT) Forecast by Countries (2017-2022)
Figure Africa HER2 Antibodies Sales Market Share Forecast by Countries (2017-2022)
Table Africa HER2 Antibodies Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa HER2 Antibodies Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA HER2 Antibodies Sales (MT) Forecast by Type (2017-2022)
Figure EMEA HER2 Antibodies Sales Market Share Forecast by Type (2017-2022)
Table EMEA HER2 Antibodies Sales (MT) Forecast by Application (2017-2022)
Figure EMEA HER2 Antibodies Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources